DNA-PK-IN-6 is used to inhibit DNA-PKcs activity, thereby significantly impairing DNA repair in tumor cells and inducing apoptosis; it enhances tumor sensitivity to radiotherapy, overcomes drug resistance, and potentiates the suppression of various solid and hematological tumors.